Recombinant poxvirus

Details Recombinant poxvirus Recombinant poxvirus

2008-06-10

2008-06-10

Campell, Bruce (Department: 1648)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Virus or component thereof

C424S205100, C424S199100, C435S235100, C435S236000

Reexamination Certificate

active

07384643

ABSTRACT:
Use for novel chemokine-binding protein designated A41L, and chemokine-binding fragments thereof, for the treatment of conditions such as inflammation. The A41L protein binds to chemokines in the CXC group.

REFERENCES:
patent: 5834419 (1998-11-01), McFadden et al.
patent: 6184358 (2001-02-01), Loetscher et al.
patent: 6335252 (2002-01-01), Oishi et al.
patent: 6355252 (2002-03-01), Smith et al.
patent: 9633730 (1996-10-01), None
Jackson et al. J. Virology, vol. 75, p. 1205-1210.
Patel et al., “DNA Sequence of the Gene Encoding a Major Secreted Protein of Vaccinia Virus, Strain Lister,” 1990, pp. 2013-2021, vol. 71, No. 9, Journal of General Virology, Reading, Berks, GB.
Virology; vol. 180; Howard et al.; “Vaccinia Virus Homologues of the Shope Fibroma Virus Inverted Terminal Repeat Proteins and a Discontinous ORF Related to the Tumor Necrosis Factor Receptor Family”; Jan. 1991; pp. 633-647.
Current Opinion In Immunology; vol. 8; No. 4; Geoffrey L. Smith; “Virus Proteins That Bind Cytokines, Chemokines or Interferons”; Aug. 1996; pp. 467-471.
Journal Of Experimental Medicine; vol. 184; No. 3; Loetscher et al.; “Chemkoine receptor specific for IP10. and MIG: Structure, Function, and Expression in Activated T-lymphocytes”; Sep. 1996; pp. 963-969.
Ng, Aylwin, Ph.D. Thesis, University of Oxford (1998). The Vaccina Virus A41L Gene Encodes a Novel Secreted Immunomodulatory Factor.
Ng, A. Tscharke, D.C., Reading, P.D. & Smith, G.L. (2001). The vaccina virus A41L protein is a soluble 30kDa protein that affects virus virulence. Journal of General Virology 82 2095-2105.
Nikolaevich et al. Two types of detections in Orthopoxvirus genomes. Virus Genese. vol. 9, No. 3 (1995) pp. 231-245.
Jackson et al. Expression of mouse interleukin-4 by a recombinant ectomelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousempox. Journal of Virology. vol. 75, No. 3 (2001) pp. 1205-1210.

Affiliated with

Also associated with

Rating

Recombinant poxvirus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant poxvirus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant poxvirus will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2804969